Skip to main content

Language: English / GĂ idhlig

Loading…

Chamber and committees

Question reference: S5W-25239

  • Asked by: Linda Fabiani, MSP for East Kilbride, Scottish National Party
  • Date lodged: 10 September 2019
  • Current status: Answered by Jeane Freeman on 23 September 2019

Question

To ask the Scottish Government what assurances it can give to doctors regarding the use of cannabis-based products for medicinal use (CBMPs).


Answer

The decision of whether or not to prescribe CBPMs is ultimately one for clinicians to make in accordance with their professional duties. Clinicians are expected to work with individual patients or, where appropriate, their carers to agree the best treatment taking into account the clinical evidence base, General Medical Council prescribing guidance on licensed, off label and unlicensed medicines, and local governance systems. This is in line with normal clinical practice.

The Scottish Government produced support and guidance to clinicians which was issued on 31 October 2018. Further to this, supplementary information on cannabis based products for medicinal use was issued on 21 November 2018.